rxstat › Shortages › Meropenem
Meropenem shortage status
Partial shortage
Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Meropenem products are in shortage in Canada (2 of 11 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
In shortage since
Jun 7, 2024
Talk to your pharmacist. Pharmacists can often substitute another manufacturer's version, a different strength, or (in most provinces) adapt or renew a prescription on the spot. Your free provincial health line is 811.
Reports by product
Active shortageTARO-MEROPENEM
500MG · POWDER FOR SOLUTION · SUN PHARMA CANADA INC
DIN 02421518 · since Jun 7, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortageTARO-MEROPENEM
1G · POWDER FOR SOLUTION · SUN PHARMA CANADA INC
DIN 02421526 · since Jun 14, 2024, no end estimate · Disruption of the manufacture of the drug.
ResolvedMEROPENEM FOR INJECTION
500MG · POWDER FOR SOLUTION · EUGIA PHARMA INC.
DIN 02528819 · ended Jan 5, 2026 · Delay in shipping of the drug.
ResolvedMEROPENEM FOR INJECTION
500MG · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02378787 · ended Jan 13, 2025 · Disruption of the manufacture of the drug.
ResolvedMEROPENEM FOR INJECTION
1G · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02378795 · ended Jan 13, 2025 · Delay in shipping of the drug.
ResolvedMEROPENEM FOR INJECTION
1G · POWDER FOR SOLUTION · STERIMAX INC
DIN 02493349 · ended Dec 9, 2024 · Delay in shipping of the drug.
ResolvedMEROPENEM FOR INJECTION
500MG · POWDER FOR SOLUTION · STERIMAX INC
DIN 02493330 · ended Dec 9, 2024 · Delay in shipping of the drug.
ResolvedTARO-MEROPENEM
1G · POWDER FOR SOLUTION · SUN PHARMA CANADA INC
DIN 02421526 · ended Jul 25, 2023 · Disruption of the manufacture of the drug.
ResolvedTARO-MEROPENEM
500MG · POWDER FOR SOLUTION · SUN PHARMA CANADA INC
DIN 02421518 · ended Jul 16, 2023 · Disruption of the manufacture of the drug.
ResolvedMEROPENEM FOR INJECTION
500MG · POWDER FOR SOLUTION · AURO PHARMA INC
DIN 02462885 · ended Jul 7, 2020 · Demand increase for the drug.
ResolvedMEROPENEM FOR INJECTION
1G · POWDER FOR SOLUTION · AURO PHARMA INC
DIN 02462893 · ended Jul 7, 2020 · Demand increase for the drug.
DiscontinuedMERREM
500MG · POWDER FOR SOLUTION · PFIZER CANADA INC
DIN 02218488
Showing 12 of 16 reports. All reports are on file with Health Canada.
What's happening
Meropenem is currently affected by 2 active shortage reports filed with Health Canada by SUN PHARMA CANADA INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Meropenem is classified under “OTHER BETA-LACTAM ANTIBACTERIALS” (ATC J01DH).
Recent changes
Common questions
When will Meropenem be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Meropenem in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Guides: what to do when your medication is in shortage · how to read shortage reports
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.